GNRH1 and pneumothorax: Large-scale evidence supports the role of postoperative hormonal therapies (e.g., DNG, OC, GnRH agonists/antagonists) in reducing recurrence in thoracic endometriosis-related pneumothorax (TERP), a major component of TES (7).